FDA approach to the regulation of drugs for diabetes.
Fleming
A
A
Worldwide Clinical Trials, Inc, Division of Endocrine and Metabolic Drug Products, Food and Drug Administration, Chevy Chase, MD 20815, USA.
D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation / Q000331:legislation & jurisprudence; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D015507:Drugs, Investigational; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000097:blood; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D001786:Blood Glucose; D015507:Drugs, Investigational; D007004:Hypoglycemic Agents; D007328:Insulin